Abbott Laboratories (ABT)

Cost of Revenue

$5.59B

Quarterly · Period ending: · USD

ABT logo

ABT Cost of Revenue

Latest reported$5.59B
ABT Quarterly Cost of Revenue ($0.00 → $5.59B)
High-resolution chart · PNG

ABT cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
2,040,899,000
1,983,064,000
1,643,318,000
1,696,440,000
1,515,505,000
1,530,254,000
1,496,447,000
1,532,767,000
1,584,643,000
1,410,942,000
1,448,831,000
1,441,688,000
1,375,010,000
1,297,770,000
1,279,973,000
1,259,462,000
1,241,842,000
1,217,043,000
1,327,331,000
1,254,587,000
1,177,247,000
1,143,947,000
1,156,217,000
1,080,618,000
1,070,253,000
1,086,023,000
1,088,911,000
1,066,912,000
1,015,831,000
946,816,000
964,272,000
1,323,727,000
792,400,000
754,700,000
813,900,000
808,500,000
781,200,000
755,900,000
731,800,000
742,000,000
672,800,000
679,300,000
666,900,000
713,200,000
637,100,000
607,500,000
596,300,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.